The Patent Finder

Olatec Therapeutics LLC

41 patents currently held · Updated Nov 19, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Olatec Industries LLC (to 2016)

0
Ending by 2030
Dec 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 14, 2027
    The maintenance fee for Method for treating skin inflammatory diseases (US 9,078,869) comes due Jan 14, 2027. Unpaid by Jul 14, 2027, it lapses early.
  • 1 fee due Feb 25, 2027
    The maintenance fee for Compounds for treating inflammation and pain (US 9,114,122) comes due Feb 25, 2027. Unpaid by Aug 25, 2027, it lapses early.
  • 2 fees due Apr 6 to 15, 2027 · next Apr 6
  • 2 fees due Jun 8 to 10, 2027 · next Jun 8
  • 1 fee due Jul 2, 2027
    The maintenance fee for Methods for treating melanoma (US 11,857,529) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
  • 1 fee due Aug 4, 2027
    The maintenance fee for Method for treating multiple sclerosis (US 10,548,870) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
  • 1 fee due Sep 8, 2027
    The maintenance fee for Method for treating contact dermatitis (US 9,278,082) comes due Sep 8, 2027. Unpaid by Mar 8, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,476,3163-methanesulfonylpropionitrile for treating inflammation and pain
In force
 · USPTO record
In forceUSPTO record
US 8,829,0463-methanesulfonylpropionitrile for treating inflammation and pain
In force
 · USPTO record
In forceUSPTO record
US 8,975,2973-Methanesulfonylpropionitrile for Treating Inflammation and Pain
In force
 · Medium confidence
In forceMedium confidence
US 9,492,4203-methanesulfonylpropionitrile for treating inflammation and pain
In force
 · USPTO record
In forceUSPTO record
US 9,770,4283-methanesulfonylpropionitrile for treating inflammation and pain
In force
 · USPTO record
In forceUSPTO record
US 10,080,7353-methanesulfonylpropionitrile for treating inflammation and/or pain
In force
 · USPTO record
In forceUSPTO record
US 10,500,1843-methanesulfonylpropionitrile for treating inflammation and/or pain
In force
 · USPTO record
In forceUSPTO record
US 11,229,6203-methanesulfonylpropionitrile for treating inflammation and/or pain
In force
 · USPTO record
In forceUSPTO record
US 8,802,885Process for preparing 3-methylsulfonylpropionitrile
In force
 · USPTO record
In forceUSPTO record
US 9,024,056Crystalline Form of 3-Methylsulfonylpropionitrile
In force
 · Medium confidence
In forceMedium confidence
10 of 41 patents shown.
Pro members see all 41.
Pro members: see all 41 patents
Also on record, not counted in the 41: 2 lapsed for an unpaid fee · 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 3 abandoned · 3 no status recorded

Showing 1 to 9 of 9, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/820,156Methods for Treating Solid Cancer Patients with Clonal Hematopoiesis of Indeterminate PotentialAug 29, 2024Pending
18/767,860Methods for Treating Pancreatic CancerJul 9, 2024Pending
18/444,049Method for Treating Parkinson's DiseaseFeb 16, 2024Pending
18/185,935Pharmaceutical Composition for Treating Inflammation and PainMar 17, 2023Abandoned
17/457,420Method for Treating AsthmaDec 2, 2021Abandoned
17/995,167Mar 26, 2021No status recorded
17/001,124Pharmaceutical Composition for Treating Inflammation and PainAug 24, 2020Abandoned
16/785,917Feb 10, 2020No status recorded
15/046,707Feb 18, 2016No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited